Visiopharm

Visiopharm is the global leader in Augmented Pathology solutions, which include precision pathology and high-throughput pathology for tissue diagnostics and research. Leading biopharmaceutical companies, contract research organizations (CROs), academic medical centers, and diagnostic pathology laboratories worldwide use the Oncotopix platform for tissue-based research and diagnostics. Recent advancements in artificial intelligence and deep learning have further solidified Oncotopix as the most comprehensive and configurable tissue analysis solution currently on the market. Their solutions are featured in over 1,300 peer-reviewed scientific publications and are compatible with leading slide scanner manufacturers and data management software. Visiopharm is certified to EN ISO 13485:2016, covering the design, development, manufacturing, installation, and servicing of in vitro diagnostic pathology software.